Baxter International Stock Jumps After Earnings Beat, But Novum Pump Risk Still Hangs Over 2026
Baxter reported first-quarter adjusted earnings of 36 cents per share on $2.7 billion revenue, topping Wall Street forecasts. The company kept its 2026 earnings outlook unchanged. Shares rose about 4% to $17.60 by midday. Margins remain pressured by tariffs, oil prices, and Novum IQ LVP pump issues.